Taken together, our results provide suggestive evidence that there is a molecular signature of expression and splicing changes, possibly driven by SRRM1 that is predictive of bad prognosis in B-ALL and that is independent of the fusion background. This evidence concerns the gene SRRM1 and acute lymphoblastic leukemia.